The assessment and management of patients with acute asthma

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 4, 2006, Pages 356-364

  Behbehani, N ^a   FitzGerald, J Mark ^b,c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Acute asthma; Assessment; Treatment

Indexed keywords

AMINOPHYLLINE; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE; HYDROCORTISONE; IPRATROPIUM BROMIDE; MAGNESIUM; MAGNESIUM SULFATE; METHYLPREDNISOLONE; PLACEBO; PREDNISONE; SALBUTAMOL; STEROID; THEOPHYLLINE;

AIRWAY OBSTRUCTION; ANAMNESIS; ASTHMA; BLOOD GAS ANALYSIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE EXACERBATION; DRUG COST; DRUG DOSE REGIMEN; DRUG MECHANISM; EXPIRATORY RESERVE VOLUME; HUMAN; METERED DOSE INHALER; OUTCOME ASSESSMENT; OXIMETRY; OXYGEN THERAPY; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY;

ACUTE DISEASE; ASTHMA; BRONCHODILATOR AGENTS; GLUCOCORTICOIDS; HUMANS; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 33645673408     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Masoli M, Fabian D, Holt S, Beasley R. Global burden of asthma. A report developed for the Global Initiative of Asthma, 2004. www.ginasthma.com
2. FitzGerald J M. Burney P, Kuramto L, Abu Laban R and the GASP study group. Emergency and continuing care for asthma in North America: a prospective evolution of asthma managemetn in Vancouver. [Abstract] Int J Tuberc Lung Dis 2004; 8(Suppl 1):S7.
3. Awadh N, Grunfeld A, FitzGerald J M. Health care costs associated with acute asthma. A prospective economic analysis. Can Respir J 1999; 6: 521-525.
4. Smith D H, Weiss K, Sullivan S D. Epidemiology and costs of acute asthma. In: Hall J B, Corbridge T, Rodrigo C, Rodrigo G, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000: 1-10.
5. Krahn M D, Berka C, Langlois P, Detsky A S. Direct and indirect costs of asthma in Canada, 1990. CMAJ 1996; 154: 821-831.
6. Toelle B G, Ram F S. Written individualised management plans for asthma in children and adults. Cochrane Database Syst Rev 2002; CD002171.
7. Powell H, Gibson P G. Options for self-management education for adults with asthma. Cochrane Database Syst Rev 2003; CD004107.
8. Rodrigo G J, Rodrigo C, Hall J B. Acute asthma in adults: a review. Chest 2004; 125: 1081-1102.
9. Global Strategy for Asthma Management and Prevention. Publication No 02-3659. Bethesda, MD: NIH, 2002. www. ginasthma.com/Guidelineitem.aspPintId = 82
10. Ait-Khaled N, Enarson D. Management of asthma in adults. A guide to essentials of good practice. 2nd ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2005. www.iuatld.org
11. Rea H H, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland D C. A case-control study of deaths from asthma. Thorax 1986; 41: 833-839.
12. Turner M O, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald J M. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998; 157: 1804-1809.
13. Spitzer W O, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501-506.
14. Kolbe J, Fergusson W, Garrett J. Rapid onset asthma: a severe but uncommon manifestation. Thorax 1998; 53: 241-247.
15. Greenberger P A, Miller T P, Lifschultz B. Circumstances surrounding deaths from asthma in Cook County (Chicago) Illinois. Allergy Proc 1993; 14: 321-326
16. Alvarez G, Schulzer M, FitzGerald J M. Risk factors for near fatal asthma-a meta analytic review. Can Resp J 2005; 5: 265-270
17. Brenner B E, Abraham E, Simon R R. Position and diaphoresis in acute asthma. Am J Med 1983; 74: 1005-1009.
18. Blaustein A S, Risser T A, Weiss J W, Parker J A, Holman B L, McFadden E R. Mechanisms of pulsus paradoxus during resistive respiratory loading and asthma. J Am Coll Cardiol 1986; 8: 529-536.
19. Corbridge T C, Hall J B. The assessment and management of adults with status asthmaricus. Am J Respir Crit Care Med 1995; 151: 1296-1316.
20. Knowles G K, Clark TJ. Pulsus paradoxus as a valuable sign indicating severity of asthma. Lancet 1973; 2: 1356-1359.
21. Jay G D, Onuma K, Davis R, Chen M H, Mansell A, Steele D. Analysis of physician ability in the measurement of pulsus paradoxus by sphygmomanometry. Chest 2000; 118: 348-352.
22. Shim C S, Williams M H, Jr. Relationship of wheezing to the severity of obstruction in asthma. Arch Intern Med 1983; 143: 890-892.
23. Paggiaro P L, Moscato G, Giannini D, Di Franco A, Gherson G. Relationship between peak expiratory flow (PEF) and FEV1. Eur Respir J Suppl 1997; 24: 39S-41S.
24. Lemarchand P, Labrune S, Herer B. Huchon GJ. Cardiorespiratory arrest following peak expiratory flow measurement during attack of asthma. Chest 1991; 100: 1168-1169.
25. Stein L M, Cole R P. Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med 1990; 112: 822-827.
26. Rodrigo G, Rodrigo C. Early prediction of poor response in acute asthma patients in the emergency department. Chest 1998; 114: 1016-1021.
27. Wilson M M, Irwin R S, Connolly A E, Linden C, Manno M M. A prospective evaluation of the 1-hour decision point for admission versus discharge in acute asthma. J Intensive Care Med 2003; 18: 275-285.
28. Carruthers D M, Harrison B D. Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax 1995; 50: 186-188.
29. 2 as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med 1994; 23: 1236-1241.
30. Nowak R M, Tomlanovich M C, Sarkar D D, Kvale P A, Anderson J A. Arterial blood gases and pulmonary function testing in acute bronchial asthma JAMA 1983; 249: 2043-2046.
31. Martin T G, Elenbaas R M, Pingleton S H. Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acute asthma. Ann Emerg Med 1982; 11: 70-73.
32. Mountain R D, Heffner J E, Brackett N C Jr, Sahn S A. Acid base disturbances in acute asthma. Chest 1990; 98: 651-655.
33. Findley L J, Sahn S A. The value of chest roentgenograms in acute asthma in adults. Chest 1981; 80: 535-536.
34. Zieverink S E, Harper A P, Holden R W, Klatte E C, Brittain H. Emergency room radiography of asthma: an efficacy study. Radiology 1982; 145: 27-29.
35. Rodrigo G, Rodrigo C. Assessment of the patient with acute asthma in the emergency department. A factor analytic study. Chest 1993; 104: 1325-1328.
36. Mallmann F, Fernandes A K, Avila E M, et al. Early prediction of poor outcome in patients with acute asthma in the emergency room. Braz J Med Biol Res 2002; 35: 39-47.
37. Rodrigo G J, Rodrigo C. Continuous versus intermittent beta agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002; 122: 160-165.
38. Gates C. Holding chambers versus nebulisers for beta agonist treatment of acute asthma. Cochrane Database Syst Rev 2003; (3): CD 000052.
39. Turner M, Patel A, Ginsberg S, FitzGerald JM. Bronchodilator therapy in acute airflow obstruction: a meta-analysis. Arch Intern Med 1997; 157: 1736-1744.
40. Travers A, Jones A P, Kelly K, et al. Intravenous beta 2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001; (2): CD002988.
41. Rodrigo G, Rodrigo C, Burschtin O. Ipratropium bromide in acute adult severe asthma: a meta-analysis of randomized controlled trials. Am J Med 1999; 107: 363-370.
42. Stoodley R G, Aaron S D, Dales R E. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999; 34: 8-18.
43. Rodrigo G J, Castro-Rodriguez J A. Anti cholinergics in the treatment of children and adults with acute asthma: a systematic review with meta analysis. Thorax 2005.
44. Rodrigo G J, Rodrigo C. First-line therapy for adult patients with acute asthma receiving multiple dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000; 161: 1862-1868.
45. Blitz M, Blitz S, Hughes R, Diner B, Beasley R, Knopp J, Rowe B. Aerosolized magnesium sulphate for acute asthma: a systematic review. Chest 2005; 128: 337-344.
46. Parameswaran K, Belda J Rowe B H. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; (2): CD002742.
47. Rodrigo G J, Rodriquez Verde M, Peregalli V, Rodrigo C. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003; 124: 1312-1317.
48. Rodrigo G J, Rodrigo C, Pollack C V, Rowe B. Use of helium oxygen mixtures in the treatment of acute asthma: a systematic review. Chest 2003; 123: 891-896.
49. Rowe B H, Keller J L, Oxman A D. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med 1992; 10: 301-310. Search date 1991.
50. Rowe B H, Spooner C H, Duchrame F M, et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2001; (1): CD000195.
51. Mahakalkar S M, Tibdewal S, Khobragade B P. Effect of a single dose of prednisolone on hospitalization in patients of acute bronchial asthma. Ind J Med Sci 2000; 54: 384-387.
52. O'Driscoll B R, Kalra S, Wilson M, Pickering C A, Carroll K B, Woodcock A A. Double-blind trial of steroid tapering in acute asthma. Lancet 1993; 341: 324-327.
53. Hasegawa T, Ishihara K, Takakura S, et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation: a randomized study. Intern Med 2000; 39: 794-797.
54. Edmonds M L, Camargo C A Jr, Pollack C V, et al. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2003; (3): CD002308.
55. Edmonds M L, Camargo CA, Brenner B E, et al. Replacement of oral corticosteroids with inhaled corticosteroids in the treatment of acute asthma following emergency department discharge: a meta-analysis. Chest 2002; 121: 1798-1805.
56. Rodrigo G J. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med 2005; 171: 1231-1236.
57. Rowe B H, Bretzlaff J A, Bourdon C, et al. Magnesium sulphate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; (2): CD001490.
58. Boonyavoroakul C, Thakkinstian A, Charoenpan P. Intravenous magnesium sulfate in acute severe asthma. Respirology 2000; 5: 221-225.
59. Porter R S, Nester S, Braitman L E, et al. Intravenous magnesium is ineffective in adult asthma: a randomised trial. Eur J Emerg Med 2001; 8: 9-15.
60. Silverman R A, Osborn H, Runge J, et al. IV magnesium sulphate in the treatment of acute severe asthma: a multi centre randomized controlled trial. Chest 2002; 122: 489-497.
61. Grunfeld A, FitzGerald J M. Discharge considerations in acute asthma. Can Respir J 1996; 3: 322-324.
62. Krishan J A, Riekert K A, McCoy J V, et al Corticosteroid use after hospital discharge among high risk adults with asthma. Am J Respire Crit Care Med 2004; 170: 1281-1285.
63. Gibson P G, Powel H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003; (3): CD001108.
64. Pereger T V, Sudre P, Muntner P, et al. Effect of patient education on self- management skills and health status in patients with: a randomized controlled trial. Am J Med 2002; 113: 7-14.
65. Zeiger R S, Heller S, Mellon M H, et al. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J Allergy Clin Immunol 1991; 87: 1160-1168.
66. FitzGerald J M, Becker A, Sears M R, et al. A randomized controlled trial of doubling the dose of inhaled corticosteroids versus placebo in acuteasthma exacerbations. Thorax 2004; 59: 550-556.
67. Harrison, T W Oborne J, Newton S, Tattersfield A E. Doubling the dose of inhaled corticosteroids to prevent asthma exacerbation: a randomized controlled trial. Lancet 2004; 363: 271-275.
68. FitzGerald J M, Shragge D, Haddon J, et al. A randomized controlled trial of high dose inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can Respir J 2000; 7: 61-67.
69. Billo N. Do we need an Asthma Drug Facility? [Editorial] Int J Tuberc Lung Dis 2004; 8: 391.
70. Asthma Drug Facility. Paris, France: International Union Against Tuberculosis and Lung Disease. www.GlobalADF.org